IPO Insights & Analysis
Expert commentary, investment guides and market insights for IPO investors.
25
Articles
When the President Out-Trades Congress: Trump's $750 Million Quarter
Trump's Q1 2026 ethics filing revealed over 3,600 trades worth up to $750 million — more than all of Congress combined. Here's what it means for markets and investors.
IPO Boom 2026: Top Trends, Hot Sectors & What Investors Should Know
The 2026 IPO boom is driven by AI, mega listings, and growing investor demand. Discover the latest trends, sectors, and insights every investor should know.
May 2025 IPO Analysis: Market Revival, Mixed Listings & Key Takeaways
After a 2-month lull, May 2025 saw India's IPO market roar back — 6 major IPOs, avg 64x subscription, big listing surprises. Here's the full breakdown.
7 IPOs with Positive GMP Today (25 May 2026) — Apply or Avoid?
7 IPOs with positive grey ma7 IPOs have positive GMP today (25 May 2026). Merritronix leads at +62.4%, Q-Line Biotech at +37%. We break down each onrket premium on 25 May 2026 — ipoup.in GMP tracker
OpenAI Files for IPO at $1 Trillion Valuation — What Indian Investors Must Know
OpenAI filed confidentially for a $1 trillion IPO on May 22, 2026. Goldman Sachs and Morgan Stanley are leading the deal. Here's what Indian investors need to know before it lists in September.
Meta Layoffs 2026: Zuckerberg Fires 8,000 as AI Race Heats Up
Meta CEO Mark Zuckerberg fired 8,000 employees (10% of workforce) in May 2026, shifting 7,000 more into AI roles — even as Q1 revenue hit a record $56.3 billion.
SpaceX Stock, IPO Rumors & Market Trends: What Investors Must Know in 2026
SpaceX remains a private company, but growing IPO rumors and Starlink expansion are creating major investor interest. Here's everything you need to know about SpaceX stock opportunities.
Merritronix SME IPO GMP Today: Strong 47% Listing Gain Expected Amid Defence Sector Buzz
Merritronix SME IPO GMP jumps to ₹70, indicating a potential 47% listing gain. Read complete IPO analysis, valuation, financials, risks, and listing outlook.
Q-Line Biotec IPO Subscription Hits 4.15× on Day 1 – Strong QIB Demand Signals Heavy Listing Buzz
Q-Line Biotec IPO opens with 4.15× subscription on Day 1, driven by strong QIB and NII demand, signaling positive listing sentiment.